Dr. Jatinder Lamba appointed new associate dean for research and graduate education
Jatinder Lamba takes over for Maureen Keller-Wood, Ph.D., who plans to retire in the summer of 2023.
Posts tagged as
Jatinderlamba
Dr. Jatinder Lamba receives $3.3 million NCI grant for pediatric AML research
The $3.3 million, five-year R01 grant from National Cancer Institute will support Lamba's research of the biology of acute myeloid leukemia.
Marrero, Marchi win abstract awards at the American Society of Hematology Annual Meeting
Dr. Richard Marrero and Francisco Marchi were honored with abstract awards at the ASH Annual Meeting in New Orleans on Dec. 10.
Celebrating Distinction ceremony recognizes endowed professors and chairs
UF Health honored 33 endowed professors and chairs across the six academic colleges at a special Celebrating Distinction ceremony on Oct. 13.
UF-led research identifies genes involved in chemotherapy resistance in pediatric AML
A team led by UF researchers has used genome-wide CRISPR/cas9 screening to identify genes that are sensitive or resistant to etoposide, a chemotherapy drug used to treat pediatric acute myeloid leukemia, or AML.
UF researchers develop genetic score to improve pediatric cancer treatments
Dr. Jatinder Lamba led a study published in the Journal of Clinical Oncology how the genetic scorer brings a precision medicine approach to treating childhood acute myeloid leukemia.
Dr. Jatinder Lamba awarded $1.9 million grant to continue Acute Myeloid Leukemia study
The National Cancer Institute awarded Jatinder Lamba a five-year, $1.9 million grant to support research on Acute Myeloid Leukemia.
Dr. Jatinder Lamba named 2020 UF Research Foundation Professor
Lamba is one of 33 faculty members across the university to be named a 2020 UF Research Foundation Professor.
Four UF College of Pharmacy faculty named UF Term Professors
Larisa Cavallari, Margaret James, Jatinder Lamba and Almut Winterstein will serve three-year terms beginning in the 2019 academic year.
Dr. Jatinder Lamba secures UF Research Opportunity Seed Fund Award to develop a relapse response score for AML patients using CRISPR/Cas9 screening
The UF Office of Research awarded Lamba more than $85,000 in funding through a UF Research Opportunity Seed Fund Award to develop a relapse response score for AML patients.